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Introduction
Motor, behavioural and autonomic parasomnias are common (Karacan et al., 1976; Bixler et al., 1979; Cirignotta et al., 1983; Price Keefauver and Guilleminault, 1994) . The clinical features of the main parasomnias (sleepwalking, night terrors and nocturnal enuresis) are well known from the early 1960s Broughton, 1963, 1965) . During the same decade, a number of studies rejected the possible epileptic origin of these parasomnias before puberty Broughton, 1964, 1965; Jacobson et al., 1965; Kales et al., 1966; Broughton, 1968) . From the late 1970s, increasing information became available about complex, abnormal and often violent behaviour occurring during non-rapid eye movements sleep in adolescents and adults. Similar conditions have been described under the terms hypnogenic or nocturnal paroxysmal dystonia (Lugaresi and Cirignotta, 1981; Lugaresi et al., 1986) , paroxysmal nightmares (Boller et al., 1975) , paroxysmal awakenings or arousals (Peled and Lavie, 1986; Montagna et al., 1990) , paroxysmal periodic motor attacks (Sforza et al., 1993) , episodic or epileptic nocturnal wanderings (Pedley and Guilleminault, 1977; Maselli et al., 1988; Oswald, 1989; Plazzi et al., 1995) . In recent years, on the basis of complete video-polysomnographic monitoring, most authors agreed on the epileptic origin of these nocturnal phenomena Meierkord et al., 1992; Montagna, 1992; Hirsch et al., 1994) . On the other hand, partial epileptic seizures of frontal lobe origin are well known to be characterized by complex motor activity, verbal manifestations and sometimes urinary incontinence, all with nocturnal clustering (Tharp, 1972; Williamson et al., 1985; Waterman et al., 1987; Fusco et al., 1990; Chang et al., 1991; Munari and Bancaud, 1992; Vigevano and Fusco, 1993; Chauvel et al., 1995; Manford et al., 1996) . Moreover, in patients with nocturnal frontal lobe epilepsy, interictal and ictal surface EEGs are often normal Vigevano and Fusco, 1993; Scheffer et al., 1995; Oldani et al., 1996) .
A number of cases with a family history has been reported in patients suffering from parasomnias (sleepwalking, night terrors and nocturnal enuresis) Cirignotta et al., 1983; Blatt et al., 1991) , nocturnal paroxysmal dystonia (Lugaresi and Cirignotta, 1981; Godbout et al., 1985; Lee et al., 1985; Tinuper et al., 1990) , paroxysmal arousals Montagna, 1992) , epileptic nocturnal wanderings (Plazzi et al., 1995) , frontal lobe epilepsy (Fusco et al., 1990; Vigevano and Fusco, 1993) , and even in patients displaying sleep-related violence (Guilleminault et al., 1995; Moldofsky et al., 1995) . In particular, the frequency of sleep terrors and enuresis has been reported to be higher in families with somnambulism and the frequency of all main parasomnias has been reported to be higher in families with nocturnal paroxysmal dystonia (Lugaresi and Cirignotta, 1981) , paroxysmal arousals Montagna, 1992) , epileptic nocturnal wanderings (Plazzi et al., 1995) and sleep-related violence (Guilleminault et al., 1995; Moldofsky et al., 1995) .
Finally, some authors (Scheffer et al., 1994 Oldani et al., 1996) recently described a nocturnal frontal lobe epileptic syndrome (autosomal dominant nocturnal frontal lobe epilepsy, ADNFLE), which is often misdiagnosed as parasomnia, with autosomal dominant inheritance.
In one large Australian kindred, a genetic linkage of ADNFLE to chromosome 20q13.2 has been established . The gene coding for the neuronal nicotinic acetylcholine receptor α 4 subunit (CHRNA4), which has recently been cloned (Steinlein et al., 1996) maps in the same chromosome region (20q13.2-q13.3) (Steinlein et al., 1994) . A missense mutation of exon 5 of this gene associated with ADNFLE in the same Australian kindred has been reported (Steinlein et al., , 1996 . This mutation replaces serine, a strongly conserved amino acid residue in the second transmembrane domain with phenylalanine (Ser252Phe). In this same region, two other C→T transitions, at positions 555 and 594, respectively (not leading to amino acid substitutions) have been detected in the same kindred (Steinlein et al., 1996) .
The aims of the present study were to describe the clinical and EEG characteristics of a large sample of patients suffering from ADNFLE, to outline its differential diagnosis from 'typical' parasomnias and to check whether the same missense mutation reported by Steinlein et al. (1995) was present in our ADNFLE families.
Patients and methods
Study design
Among the consecutive patients evaluated in our Sleep Disorders Centre during the period November 1995 to July 1996 (n ϭ 1045), 94 subjects (9.0%) complained of repeated nocturnal motor and/or behavioural episodes. From this sample we selected the patients with a family history of abnormal nocturnal phenomena, obtaining an homogeneous study group of 40 patients from 30 unrelated Italian families. Extensive pedigree information was obtained and pedigrees of all families are shown in Fig. 1 . Pedigree nomenclature is according to Bennett et al. (1995) . Available living individuals, both affected patients and many unaffected family members, underwent detailed clinical assessment.
Study protocol
The study was approved by the Ethical Committee of the Istituto Scientifico H. San Raffaele, Milan and all patients signed an appropriate informed consent form and then underwent the following study protocol: (i) physical and neurological examinations; (ii) detailed sleep interview with parents or the bed partner; (iii) EEG studies during wakefulness; (iv) video-EEG studies after sleep deprivation in some (six out of 40); (v) neuroradiological (MRI) examinations in some (28 out of 40); and (vi) nocturnal video-polysomnography (after an adaptation night to the laboratory) including EEG monitoring (at least eight bipolar leads positioned according to the International 10-20 System), electrooculogram, submental electromyography, ECG and, in most cases, electromyography of arms and legs and abdominal and/or thoracic respiratory movements.
The patients were monitored all night with a video (splitscreen system) and the recordings were analysed for abnormal behaviour and/or motor activity. The nocturnal repetitive motor activity was carefully analysed and classified into four classes of episodes: minimal, minor, major and prolonged, according to duration, semeiology and complexity of motor behaviour (Sforza et al., 1993; Oldani et al., 1996; Zucconi et al., 1996) as follows.
Minimal. Simple motor acts of body touching (such as scratching or rubbing the nose or head), limb flexion, chewing, facial grimacing, vocalization, moaning or simple body movements (duration of 3-10 s).
Minor. Motor acts with the involvement of more body segments, with purposeful or semi-purposeful behaviour, such as gross body movements, change in body position and/ or rhythmic movements (duration of 10-30 s).
Major. Sudden and abrupt body or segmental movements such as elevation of head and trunk, hyperextension of arms and trunk accompanied by dystonic or clonic movements, fearful expression and panic sensation (duration of 5-30 s).
Prolonged. Complex motor behaviour with tonic-dystonic posture, bimanual and bipedal activity, axial movements, shouting, laughing and deep breathing (duration of Ͼ1 min).
In order to provide a differentiation between minimal/ minor attacks and physiological nocturnal body movements we compared the video-polysomnographic recordings of patients and healthy subjects (Oldani et al., 1996) . Healthy subjects did not show any major or prolonged attacks, but had some nocturnal movements that could resemble minimal/ minor attacks. Nevertheless, the semiology of these attacks, in particular of minimal ones, was quite different between the patients and healthy subjects; the patients had a great stereotypy in all types of attacks, showing sudden and abrupt movements, always with a dyskinetic or dystonic component.
Two neurologists, expert in sleep medicine (A.O. and M.Z.) , analysed all the video-polysomnographical recordings. Concerning the classification of the different episodes and the distinction between minimal/minor attacks and nocturnal movements of healthy subjects, the inter-observer and intraobserver variability of scoring was very low (Ͻ5%) and nonsignificant. Sleep was scored according to international criteria (Rechtschaffen and Kales, 1968) .
PCR (polymerase chain reaction) conditions
PCR amplifications were carried out in a 480 thermal cycler (Perkin Elmer) in a total volume of 50 µl containing 50 ng of genomic DNA extracted from blood samples, ϫ1 reaction buffer (Promega), 1.5 mM MgCl 2 , 200 µM dNTPs and 0.4 M primers. Oligonucleotide primer pair sequences used to amplify the region of exon 5 of CHRNA4 gene, lying between nucleotides 535 and 825, were 5F 5Ј-GGCGA-GTGGGTCATCGTGG-3Ј and 5R 5Ј-GATGACCAGTGAG-GTGGACG-3Ј (Steinlein et al., 1996) . Taq DNA polymerase (2.5 U) (Promega) was added after 5 min denaturation at 95°C, immediately before starting 30 amplification cycles performed as follows: 95°C for 30 s, 57°C for 30 s, 72°C for 30 s; finally the samples were further extended for 10 min at 72°C.
PCR products were separated electrophoretically on 1.5% agarose gels and eluted using the QIAquick gel extraction kit (Qiagen).
DNA sequencing and analysis
Purified amplification products were sequenced from each of the above primers by the Taq dye-deoxy terminator method, according to the manufacturer's instructions, using an automated 370A DNA sequencer (Applied Biosystems). Mutation detection was performed using the Factura and Sequence Navigator software packages (Applied Biosystems).
DNA probe
D20S20 probe was a kind gift of Dr Y. Nakamura, Cancer Institute, Tokyo. TaqI identifies a two-allele polymorphism with a band at 2.5 kb (allele 1) or 2.3 kb (allele 2) with a constant band at 1.5 kb (Myers et al., 1988) . The D20S20 probe has been physically mapped within 80 kb on the centromeric side of CHRNA4 gene (Steinlein et al., 1994) . The GENEHUNTER package was used for linkage analysis (Kruglyak et al., 1996) .
Southern blot analysis
DNA, extracted from blood samples according to standard procedures (Sambrook et al., 1989) , was digested with TaqI (Boehringer), separated by 0.6% agarose/Tris acetate gel electrophoresis (10 µg per lane), transferred to nylon membranes (Amersham) and hybridized with a random primer [α-32 P]dCTP-labelled probe. Hybridization was performed at 65°C for 16 h in 5 ϫ SSC, 5 ϫ Denhardt's solution and 100 µg/ml sheared salmon sperm DNA. Filters were washed with a series of solutions ranging from 2 ϫ SSC, 0.1% SDS at room temperature for 30 min to 0.1 ϫ SSC, 0.1% SDS at 65°C for 15 min and visualized by autoradiography.
Results
Among the 40 patients from 30 unrelated families analysed in this study, the video-polysomnography was non-diagnostic in two individuals belonging to two different families. In the first case there were technical problems in the recording; in the second one, the patient had a total sleep time of only 18 min. The detailed clinical assessment of the remaining 28 families led to the recognition of another 75 affected individuals (65 living and 10 deceased) for a total number of 103 affected individuals (Fig. 1) . The clinical features of the 38 patients evaluated are summarized in Table 1 .
Clinical examination and neuroimaging studies
The age at evaluation ranged from 4 to 49 years. None of the patients had a history of severe prenatal or perinatal insult, febrile seizures, meningitis, encephalitis or any other condition that was likely to have caused seizures. None had gross evidence of intellectual disability. All the patients were right handed and had a normal neurological examination. In the 28 patients who underwent neuroradiological (MRI) examination the findings were normal.
Clinical seizures characteristics
The seizures began in childhood (mean age at onset 11.8, range 1-30 years), usually persisting throughout adult life. During the active periods of the disease, all the patients had frequent nocturnal episodes (1-20 per week), with a wide spectrum of complexity and severity, ranging from urinary incontinence to violent behaviour. There was a wide intra-familial variation in the severity of seizure disorder. There was also considerable intra-individual variation in severity, during the patient's lifetime, with clusters of seizures alternating with seizure-free periods. The seizurefree intervals usually lasted 1-4 weeks and, in any case, they were never Ͼ3 months. In most cases there was an agedependent degree of severity. The seizures were prolonged and frequent in childhood and adolescence, and tended to decrease in complexity and frequency during adulthood, although they rarely disappeared. Usually the patients were aware of a few of their nocturnal phenomena. Typically, the patients had one stereotypical episode, occurring one or more times every night, and another type (or two) of episode occurring with a lower frequency (ഛ1-2 per week). In all the cases with episodes of urinary incontinence at least another type of nocturnal episode with a higher frequency was associated. The patients did not report specific seizure trigger factors.
Daytime seizures and complaints
Fourteen patients (36.8%) reported that some seizures also occurred during wakefulness (generalized tonic-clonic seizures in four cases, generalized atonic seizures in six, complex partial seizures in the remaining four). Usually, these seizures during awake state were rare (ranging from 1 to 10 per year) and confined in the childhood and adolescence. Twenty-two patients (57.9%) reported daytime complaints as difficulty in waking, morning tiredness and/or excessive daytime sleepiness.
Video-polysomnographic data
The video-polysomnographic recordings showed a wide spectrum of episodes. All the patients showed repeated brief motor attacks (classified as minimal and minor episodes) (Table 2) , with a duration ranging from 5 to 30 s, a great stereotypy and a dystonic/dyskinetic component.
In an unexpectedly high percentage of patients (42.1%) we recorded at least one major attack, characterized by sudden elevation of head and trunk, usually with dystonic and/or clonic movements of arms, fearful expression and IV-1. During the first minute after the attack, rhythmic slow activity (post-ictal phenomenon) (see dashed lines) was evident, mainly over right temporal areas. often panic sensation (see Figs 2-4) . In five cases we recorded at least one prolonged attack, with complex and bizarre behaviour, assumption of abnormal posture, dystonic bipedal and/or bimanual movements, shouting and/or unintelligible mumbling. In three other cases we recorded at least one episode in which the verbal manifestations were predominant (see Fig. 5 ). In summary, all the patients had minimal and minor attacks; 20 (52.6%) also had major or/and prolonged attacks. In two cases (5.3%) one episode with violent behaviour was recorded (see Figs 3 and 6). None of the patients had episodes of urinary incontinence during the recordings.
The recorded episodes occurred during non-rapid eye movements sleep, both stage 2 and stage 3-4. The patients showed a substantially normal sleep profile (Table 3) . 
EEG data
The EEG findings during wakefulness and sleep are shown in Table 4 .
Ictal epileptiform abnormalities dominant over frontal areas were found in~30% of patients. While the daytime EEG was often normal (in 88.2%), the EEG during sleep showed interictal epileptiform abnormalities frontally dominant in 50% of patients. Moreover, in~55% of patients we recorded some ictal diffuse (background flattening) or focal (rhythmic theta or delta activity prominent over anterior quadrants, see Figs 2-4) EEG activity, all of which have been described as possible accompaniments of frontal lobe seizures (Munari and Bancaud, 1992; Vigevano and Fusco, 1993) , and can also be considered as a postictal phenomenon (Munari et al., 1995) . Some patients showed two different types of EEG abnormality (see Fig. 2 ), while 10 cases (26.3%) had interictal and ictal EEGs which were both normal.
Genetics
Out of 94 patients complaining of repeated nocturnal motor and/or behavioural episodes belonging to 84 families, 28 (33.3%) had more than two affected relatives. There were 28 probands and another 75 affected individuals were identified during familial data collection (Fig. 1) . Consanguineity was observed in only one family (number 9), in which two first cousins, one of them affected, married. There were 56 males and 47 females showing ADNFLE, producing a male : female ratio of 1.19. Affected parents had affected children of both sexes and male to male transmission occurred in 10 families (numbers 1, 6, 7, 8, 11, 15, 19, 25, 27 and 28) , excluding both mitochondrial and X-linked inheritance.
The analysis of all pedigrees reported in Fig. 1 is strongly suggestive of an autosomal dominant inheritance with reduced penetrance, as previously reported (Scheffer et al., 1994 . An autosomal recessive transmission, which might be compatible with some pedigrees, can be reasonably excluded, since it would require several matings between heterozygous subjects, whose frequency in the population is probably low, owing to the rarity of this disorder (up to now no epidemiological data are available). In Family 5, the disease is transmitted by two apparently unrelated persons, both living in a small isolated village of North Italy, suggesting the existence of a common ancestral relative.
Overall, 58% of affected sibships had a parent known to be affected, thus confirming that in some obligate carriers (families 1 II-3, 6 II-1, 9 I-4, 9 I-9, 9 II-7, 10 II-4, 10 II-5, 10 II-8, 13 II-1, 13 III-2, 16 II-2, 19 II-3 and 26 I-2; see Fig. 1 ) the disease was not penetrant. In other families (5, 8, 14, 18, 21, 22, 23, 24 and 25) the obligate carrier was not exactly identifiable. These data lead to a penetrance value of 81%. The high variability in the ADNFLE expression and the possibility of its disappearance during adult life, combined with the impossibility of examining all the members of the families clinically, prevented the detection of any correlation between phenotype severity and parental origin of the disease. Moreover, the impossibility of getting information on the age of onset for all generations and the apparently wide variability of onset in the known sibships (Table 5) do not allow us to exclude a possible effect of anticipation among generations.
Mutation analysis
In 20 representative ADNFLE patients from 15 families, we performed a mutation analysis of the region of exon 5 of the CHRNA4 gene, which is reported to be associated with ADNFLE (Steinlein et al., , 1996 . DNAs were PCR amplified for the exon 5 region lying between nucleotides 535 and 825, and sequenced. The results of the sequence analysis are reported in Table 6 . In none of the tested patients could the Ser252Phe mutation be identified.
Sequence analysis allowed us to confirm the presence of C→T transitions which do not lead to amino acid substitutions, at nucleotide positions 555 and 594 described by Steinlein et al. (1996) .
At nucleotide position 555, one patient out of 20 (5%) was heterozygous for the C→T transition (genotype CT) and two patients out of 20 (10%) were homozygous for this transition (genotype TT). At nucleotide position 594, four patients out of 20 (20%) were heterozygous for the same transition (genotype CT).
Linkage analysis
Linkage of ADNLFE to the CHRNA4 locus on chromosome 20 has been analysed on five compliant families. To this purpose, the two intragenic polymorphisms at positions 555 and 594 of exon 5 of CHRNA4, and an extragenic polymorphic locus identified by the D20S20 probe, were used physically mapping within 80 kb on the centromeric side of CHRNA4 (Steinlein et al., 1994) .
Segregation data for the five families on which analysis was performed are reported in Fig. 7 .
In two families (7 and 10), linkage has been excluded on the basis of the segregation of intragenic polymorphisms. As far as Family 7 is concerned, two affected sisters (III-2 and III-3) inherited two different regions of chromosome 20 from the affected father (II-1), while in Family 10, each of two affected brothers (III-3 and III-4) inherited different sets of chromosome 20 from the parents, at least in the analysed region. In three additional families (5, 9 and 12), in which intragenic polymorphisms were non-informative, linkage of ADNFLE to chromosome 20 has been excluded as a result Totals  17  1  2  16  4  0  20  0  0  Percentages  85  5  10  80  20  0  100  0  0 ADNFLE ϭ autosomal dominant nocturnal frontal lobe epilepsy. DNA from 20 representative affected patients was PCR-amplified for the exon 5 region lying between nucleotides 535 and 825. The PCR fragments were analysed by sequencing. Numbering of nucleotide positions of the CHRNA4 gene is according to Steinlein et al. (1996) . *This C→T transition does not lead to an amino acid substitution, nor create nor eliminate a restriction site. † This C→T transition does not lead to an amino acid substitution, but abolishes a CfoI restriction site (Steinlein, 1995) . ‡ This C→T transition replaces serine with phenylalanine and has been shown to be associated with ADNFLE .
of segregation analysis of the polymorphic alleles of the D20S20 locus. In Family 5, from the marriage between an affected woman (III-3), homozygous for the intragenic polymorphisms and heterozygous at the D20S20 locus, and a man (III-4), homozygous for the 2.5-kb D20S20 fragment (allele 1), two affected siblings (IV-1 and IV-2) were generated. While IV-1 was homozygous for the 2.5-kb allele, IV-2 was heterozygous at this locus. They must therefore have inherited two different chromosomes 20 from the affected mother. In Family 9, a non-penetrant woman (I-9), homozygous for the intragenic polymorphisms and heterozygous at the D20S20 locus, married a man with the same genotype. Among the three affected siblings, two (II-11 and II-12) were homozygous for the 2.3 kb and for the 2.5 kb D20S20 fragments (alleles 2 and 1), respectively. They must therefore have inherited two different parts of chromosome 20 from the mother. In Family 12, an affected woman (I-2), heterozygous at the D20S20 locus, married a man (I-1) homozygous for the 2.3-kb fragment of the D20S20 locus (allele 2). One of the affected sons (II-2) was homozygous for the 2.3-kb allele: he must therefore have inherited the chromosome carrying this allele from the mother; in contrast, the second affected son (II-3) was heterozygous at the D20S20 locus. Since the father is homozygous for the 2.3-kb fragment (allele 2) of this locus, II-3 must have inherited the second chromosome 20, carrying the 2.5 kb fragment (allele 1) from the mother.
The above conclusions are supported by the results of the LOD score on the analysed families, performed with the computer package GENEHUNTER (Kruglyak et al., 1996) . Multipoint analysis gave LOD scores of -3.83 and -4.23 for the two markers. Moreover, by performing a nonparametric LOD score (NPL) analysis using all the data, negative values were obtained for the NPL score. Table 5 summarizes the clinical, EEG and videopolysomnographical data for each patient.
Diagnostic considerations
Four patients (10.5%) had unequivocal evidence that they suffered from epilepsy, since they showed both seizures during wakefulness and clear-cut ictal EEG epileptiform abnormalities during sleep.
Four additional patients (10.5%) had strong evidence that they suffered from epilepsy, since they showed seizures during wakefulness and clear-cut interictal EEG epileptiform abnormalities during sleep. Twenty-six patients (68.5%) had evidence of epilepsy since they showed: seizures during Often the patients had received two, and sometimes three, different diagnoses.
wakefulness, ictal EEG abnormal activities and nocturnal major/prolonged attacks (three patients); seizures during wakefulness and ictal EEG abnormal activities (one); seizures during wakefulness alone (two); interictal and/or ictal EEG epileptiform abnormalities and major/prolonged attacks (four); ictal EEG abnormal activities and major/prolonged attacks (four); interictal and/or ictal EEG epileptiform abnormalities (eight); major/prolonged attacks alone (four). The remaining four patients (10.5%) had neither seizures during wakefulness nor ictal-interictal EEG abnormalities. Moreover, they did not show major/prolonged attacks during the nocturnal recording. Nevertheless, like all the other patients, these four also showed, during the videopolysomnographic recordings, repeated brief motor seizures (minimal and minor episodes) whose stereotypy and semeiology provided a clear differentiation from the nocturnal movements of healthy subjects (Oldani et al., 1996) . Misdiagnoses in the past were common in these patients (Table 7) , and a diagnosis of epilepsy had been given in only seven (18.4%) of them.
Follow-up and therapy
At present, 15 patients have crossed the 6-month point of pharmacological follow-up. In 11 (73.3%; eight treated with carbamazepine, two with clonazepam and one with lamotrigine) the diurnal seizures were readily controlled, as were daytime complaints; the nocturnal seizures were greatly reduced in frequency and complexity, and, in some cases, completely controlled.
Discussion
Henri Gastaut and the Marseille School, during the 1960s, described the clinical features of the main 'typical' motor and autonomic parasomnias and contemporaneously decreed the premature death of the epileptic origin of these phenomena, even when they showed up in patients with otherwise clear-cut epileptic seizures and epileptiform EEG abnormalities (Gastaut and Broughton, 1963 , 1964 Broughton, 1968; Tassinari et al., 1972) . These findings seemed to be confirmed by some contemporary American authors (Jacobson et al., 1965; Kales et al., 1966) and also by other studies performed some years later (Fisher et al., 1970a, b) . The horizons of parasomnias have been widened since the late 1970s, with the description of abnormal, bizarre and often aggressive sleep-related behaviour in a population of late teenagers and young adults by Pedley and Guilleminault (1977) , who suggested an atypical form of nocturnal epilepsy and called it episodic nocturnal wanderings. During the 1980s, similar cases with sleeprelated abnormal motor and/or behavioural phenomena have been described under different terms, as hypnogenic or nocturnal paroxysmal dystonia (Lugaresi and Cirignotta, 1981; Lugaresi et al., 1986) , paroxysmal awakenings or arousals (Peled and Lavie, 1986; Montagna et al., 1990) , paroxysmal periodic motor attacks (Sforza et al., 1993) , episodic nocturnal wanderings (Maselli et al., 1988; Oswald, 1989) .
Finally, during the early 1990s, on the basis of complete video-polysomnographic monitoring, in some cases also with deep-electrode recordings, the epileptic origin of these 'atypical' nocturnal phenomena has been clearly implicated Montagna, 1992; Meierkord et al., 1992; Hirsch et al., 1994; Plazzi et al., 1995) .
In fact, frontal lobe seizures are well known to have some clinical (prominent motor and behavioural manifestations and nocturnal clustering) and EEG (interictal and ictal surface EEG often normal) characteristics strongly resembling those of 'typical' parasomnias (Tharp, 1972; Williamson et al., 1985; Waterman et al., 1987; Fusco et al., 1990; Chang et al., 1991; Munari and Bancaud, 1992; Vigevano and Fusco, 1993; Chauvel et al., 1995; Manford et al., 1996) .
Moreover, concerning the 'typical' parasomnias, the more recent studies rejecting the possible epileptic origin of the abnormal nocturnal phenomena have often been conducted with methodological limitations (i.e. lack of video monitoring or an insufficient number of EEG channels) Gillin et al., 1982; Halasz et al., 1985; Blatt et al., 1991) . Other authors (Kavey et al., 1990) provided doubtful conclusions.
The myth concerning the association between abnormal sleep-related behaviour, particularly if violent, and substantial psychopathology has been debunked essentially by three large population studies (Schenck et al., 1989; Guilleminault et al., 1995; Moldofsky et al., 1995) , which ascribed the violent behaviour to different pathologies, such as as night terrors, sleepwalking, REM (rapid eye movement) sleep behaviour disorder and, occasionally, to nocturnal epilepsy. Nevertheless, these authors focused their attention mainly on clinical, social and psychopathological data rather than on polysomnographical ones. Guilleminault et al. (1995) , performed a really wide neurophysiological evaluation, including a sleep-deprived EEG, nocturnal polysomnography and ambulatory EEG monitoring. According to these authors, nocturnal polysomnography alone was not very helpful in defining the abnormal nocturnal behaviour, while repeated ambulatory monitoring was a particularly helpful diagnostic tool. In our experience, it is very difficult to make a correct diagnosis by means of a non-attended device without video monitoring in such a condition of abnormal behaviour and motor activity. In contrast, in the present study, despite the rarity of prolonged attacks recorded, a complete video-polysomnographic monitoring was diagnostic in 95% of patients.
Finally, a clear familial clustering in patients with abnormal sleep-related motor and behavioural phenomena has been reported by several authors under different terms Lugaresi and Cirignotta, 1981; Cirignotta et al., 1983; Godbout et al., 1985; Lee et al., 1985; Montagna et al., 1990; Tinuper et al., 1990; Blatt et al., 1991; Montagna, 1992; Plazzi et al., 1995) , including frontal lobe epilepsy (Fusco et al., 1990; Vigevano and Fusco, 1993) , and sleeprelated violent behaviour (Guilleminault et al., 1995; Moldofsky et al., 1995) .
Diagnostic considerations
Recently, Scheffer et al. (1994) recognized a nocturnal form of frontal lobe epilepsy with clear-cut autosomal dominant inheritance which is often misdiagnosed as sleep disorder. The clinical features of this syndrome were described later by the same authors . These clinical and polysomnographic features have been further delineated by ourselves in 12 patients (Oldani et al., 1996) , but at that time, due to the relatively small sample, we were not able to perform a complete clinical-genetic study. With the present extensive video-polysomnographic evaluation we broadened the clinical spectrum of ADNFLE, including all the main features of the so-called 'typical' parasomnias, and added a genetic appraisal. Interestingly, in the literature many of the patients diagnosed as having a 'typical' parasomnia had been evaluated by clinical assessment alone or associated with incomplete neurophysiological studies. In contrast, almost all the cases described in the literature which, like our patients, have been evaluated with a full video-polysomnographic monitoring have finally been diagnosed as having a nocturnal form of partial epilepsy. Therefore, we really believe that the prevalence of familial cases of 'typical' parasomnias is much lower that one might suppose. In fact, Ͼ80% of our patients received a previous misdiagnosis of parasomnia, and~20% did not receive a definite diagnosis. It might be reasonable to suppose that the patients with a 'typical' familial parasomnia (occasional episodes disappearing before puberty) rarely refer to their general practitioner and never to a neurologist or to a specialist in sleep medicine. It might also be supposed that most adult cases with a mild form of such a disease (parasomnia or epilepsy) rarely refer to a physician. In fact, all our patients with the milder forms of disease (rare nocturnal episodes without violent behaviour; and no daytime seizures) were referred to our sleep centre after an affected parent had already been diagnosed by us. Most other cases were referred to us because of the presence of daytime complaints. It could also be reasonable to extend these considerations to non-familial cases.
In summary, patients who refer to a sleep disorders centre (or to general neurology clinics) complaining of repeated nocturnal motor and/or behavioural and/or autonomic phenomena are likely to suffer from nocturnal frontal lobe epilepsy (autosomal dominant or sporadic form) rather than parasomnias. This is particularly true when the patients also had daytime complaints and/or seizures during wakefulness. ADNFLE is probably not uncommon; nevertheless, the high number of patients we observed in a relative brief period of time (9 months) is probably due to the very low number of specialized sleep clinics (which are able to perform a complete nocturnal video-polysomnographic monitoring) around Italy (seven centres in a country of~57 million inhabitants). For this reason, every year,~1400 patients are referred to our centre, coming from all over the country. Among these,~120 complain of repeated nocturnal motor and/or behavioural and/or autonomic phenomena. Therefore, for this particular Italian situation, it is not easy to generalize our results in terms of prevalence of the disease. For this reason, further epidemiological studies need to be performed.
In any case, a full video-polysomnographic study should be proposed to all the patients complaining of repeated nocturnal motor, autonomic and behavioural episodes, in order to provide a correct diagnosis and to delineate the real prevalence and clinical impact of parasomnias.
Therapeutical considerations
In these patients with ADNFLE it is of utmost importance to provide a correct diagnosis, as an anti-epileptic therapy usually controls both nocturnal and diurnal seizures as it does daytime somnolence. These daytime complaints are probably caused by sleep fragmentation, which is related to the high number of seizure-related arousals. The sleep fragmentation has been demonstrated, by means of sleepmicrostructure analysis (Terzano et al., 1985) , in some sleeprelated pathologies, including epilepsies (Terzano et al., 1989 (Terzano et al., , 1991 Gigli et al., 1992) . In our patients, the anti-epileptic therapy also controlled daytime complaints, probably by reducing the number of seizure-related arousals and, thus, sleep fragmentation.
Genetics
The distal part of the human 20q13 chromosome is a region of special interest to brain-related research. The rare 'benign familial neonatal convulsion' (BFNC) has been linked to 20q (Leppert et al., 1989; Malafosse et al., 1992) ; subsequently a gene responsible for the human 'low voltage electroencephalogram' (EEGV1; Steinlein et al., 1992) , an autosomal dominant inherited variant of the normal human EEG (prevalence 4-5%) was mapped to the same part of chromosome 20q. More recently, a third gene, CHRNA4, coding for the α 4-subunit of the neuronal nicotinic acetylcholine receptor was identified in the same part of the genome, in the vicinity of the EEGV1 and BFNC region. This particular region of human 20q shows high homology with the MM2 region of mouse chromosome 2, representing a conserved mouse-man linkage group (Pilz et al., 1992) .
In five Australian families with ADNFLE, Scheffer et al. (1994 Scheffer et al. ( , 1995 reported an autosomal inheritance with reduced penetrance. In one of these, a large pedigree, a mutation in exon 5 of CHRNA4 was found by Steinlein et al. (1996) . This mutation, a C→T transition leading to a Ser→Phe substitution in the second transmembrane domain of the protein, cosegregates with ADNFLE in the family. In the remaining four families, the mutation was not detected, suggesting locus heterogeneity for the disease. Absence of linkage to this locus has been reported also by Berkovic et al. (1995) .
The 28 Italian pedigrees reported here show an autosomal dominant inheritance, with reduced penetrance (81%) in good agreement with published data (Scheffer et al., 1994 . Because of the high variability in the expression of ADNFLE, and the possibility of its disappearance during adult life, this value of penetrance should not be considered as an exact estimate.
We did not observe the Ser252Phe mutation, reported by Steinlein et al. (1995 Steinlein et al. ( , 1996 to be associated with this syndrome, in any of the 20 analysed ADNFLE patients.
In agreement with Steinlein et al. (1996) , we detected the single base substitutions (C→T transitions, not leading to amino acid substitutions) at positions 555 and 594, in exon 5 of the CHRNA4 gene, of some of the analysed ADNFLE patients.
These intragenic polymorphisms, together with a closely linked restriction fragment length polymorphism at the D20S20 locus, were used for segregation analysis in five compliant families. This analysis allowed us to exclude linkage between the CHRNA4 gene and ADNFLE. This conclusion was supported by the results of multipoint analysis; both LOD and NPL scores were negative.
In spite of the relatively small size of the families, the data reported here support the locus heterogeneity of ADNFLE. The locations of other neuronal nicotinic acetylcholine receptor subunits (Eng et al., 1991; Anand and Lindstrom, 1992) are candidate regions for further linkage studies in these ADNFLE families.
Delineation of ADNFLE as an epileptic syndrome and its position in the international classification of epilepsies and epileptic syndromes
Electroclinical features and familial pattern suggest that ADNFLE is a specific, mainly nocturnal, epileptic syndrome. The clinical and EEG spectra are more heterogeneous than previously described Oldani et al., 1996) . ADNFLE is a syndrome that is difficult to diagnose because its clinical manifestations strongly resemble those of parasomnias and are often limited to motor and/or behavioural nocturnal phenomena. Moreover, interictal and ictal surface EEGs are sometimes normal. For these reasons, for a long time, patients with ADNFLE have probably been diagnosed as having parasomnias. Therefore, the prevalence of this syndrome is probably underestimated. In keeping with the aetiologies of epilepsies proposed in the last classification of epilepsies and epileptic syndromes (Commission, 1989) , the ADNFLE has some criteria indicating an idiopathic origin, such as the unequivocal genetic influence, the absence of aetiological evidence and the relatively benign course, but it does not fulfil all the criteria because of the persistence throughout adult life. Nevertheless, in our opinion, the ADNFLE could be located, in the classification, among the idiopathic partial epilepsies.
